Group 1 - Actuate Therapeutics, Inc. (ACTU) closed at $6.9, with a 4.9% gain over the past four weeks, and a mean price target of $21.67 suggests a 214.1% upside potential [1] - The average price target ranges from a low of $20.00 to a high of $25.00, with a standard deviation of $2.89, indicating a strong agreement among analysts [2] - Analysts show optimism regarding ACTU's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [11] Group 2 - The Zacks Consensus Estimate for ACTU has increased by 0.9% due to one upward revision in earnings estimates over the last 30 days [12] - ACTU holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, it does provide a directional guide for price movement [14]
How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06%